These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8641733)

  • 1. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
    Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
    Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion.
    Scheuermann M; Dietz R; Willenbrock R
    Eur J Pharmacol; 1998 Apr; 347(2-3):245-52. PubMed ID: 9653889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
    Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
    Seymour AA; Abboa-Offei B; Asaad MM; Rogers WL
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
    Willenbrock R; Scheuermann M; Thibault G; Haass M; Höhnel K; Bohlender J; Luft FC; Dietz R
    Cardiovasc Res; 1999 Jun; 42(3):733-42. PubMed ID: 10533614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M; Hirth-Dietrich C; Stasch JP
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
    Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats.
    Sala C; Monopoli A; Casati C; Ardeleani G; Ongini E; Zanchetti A; Morganti A
    J Cardiovasc Pharmacol; 1994 May; 23(5):703-8. PubMed ID: 7521451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats.
    Scott JM; Barclay PL; Shepperson NB
    Eur J Pharmacol; 1993 Sep; 242(1):91-7. PubMed ID: 8223941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
    J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Little DK; Kratunis VJ; Rogers WL
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac and renal effects of growth hormone in volume overload-induced heart failure: role of NO.
    Pagel I; Langenickel T; Höhnel K; Philipp S; Nüssler AK; Blum WF; Aubert ML; Dietz R; Willenbrock R
    Hypertension; 2002 Jan; 39(1):57-62. PubMed ID: 11799079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function in high-output heart failure in rats: role of endogenous natriuretic peptides.
    Willenbrock R; Pagel I; Scheuermann M; Höhnel K; Mackenzie HS; Brenner BM; Dietz R
    J Am Soc Nephrol; 1999 Mar; 10(3):572-80. PubMed ID: 10073608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure.
    Lipkin GW; Dawnay AB; Harwood SM; Cattell WR; Raine AE
    Kidney Int; 1997 Sep; 52(3):792-801. PubMed ID: 9291201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
    Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Sybertz E
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):635-40. PubMed ID: 1380608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.
    Lipkin GW; Thuraisingham R; Dawnay AB; Harwood SM; Raine AE
    Transplantation; 1997 Oct; 64(7):1007-17. PubMed ID: 9381523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.